{
    "organizations": [],
    "uuid": "6d580d5aa598b17cd21cc00879cfd449cfae6816",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cellectar-granted-orphan-drug-desi/brief-cellectar-granted-orphan-drug-designation-for-clr-131-idUSFWN1SG1IN",
    "ord_in_thread": 0,
    "title": "BRIEF-Cellectar Granted Orphan Drug Designation For CLR 131",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9, 2018 / 6:32 PM / Updated 18 minutes ago BRIEF-Cellectar Granted Orphan Drug Designation For CLR 131 Reuters Staff 1 Min Read\nMay 9 (Reuters) - Cellectar Biosciences Inc:\n* CELLECTAR GRANTED ORPHAN DRUG DESIGNATION FOR CLR 131 TO TREAT RHABDOMYOSARCOMA Source text for Eikon: Further company coverage:",
    "published": "2018-05-09T21:30:00.000+03:00",
    "crawled": "2018-05-09T21:56:01.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "pm",
        "updated",
        "minute",
        "ago",
        "granted",
        "orphan",
        "drug",
        "designation",
        "clr",
        "reuters",
        "staff",
        "min",
        "read",
        "may",
        "reuters",
        "cellectar",
        "bioscience",
        "inc",
        "cellectar",
        "granted",
        "orphan",
        "drug",
        "designation",
        "clr",
        "treat",
        "rhabdomyosarcoma",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}